SIGLEC15 and cancer: In our previous study, a novel Siglec‐15 antibody was prepared and showed encouraging tumor‐inhibitory effectiveness in LUAD by modulating macrophage polarization, suggesting a detrimental factor of Siglec‐15 role in cancer management.32